Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
GlobalRPh RX List - CRESTOR
Product / population
Rosuvastatin - CRESTOR tablets; selected renal passages, not a complete prescribing monograph.
Renal method
Creatinine clearance printed as CLcr in mL/min/1.73 m2; indexed, not silently converted to unindexed CrCl or eGFR.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-09
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Preserve indexed creatinine-clearance units and the nondialysis qualification
The RX renal instruction is explicitly indexed and excludes hemodialysis from the stated severe-renal regimen.
What to reconcile: Do not silently relabel the metric or extend the nondialysis regimen to dialysis. Review other myopathy and interaction risks.
GlobalRPh-hosted RX List · Rosuvastatin - CRESTOR tablets; selected renal passages, not a complete prescribing monograph.
Renal method: Creatinine clearance printed as CLcr in mL/min/1.73 m2; indexed, not silently converted to unindexed CrCl or eGFR. Source date: Source revision date not established in selected retrieval. Retrieved: 2026-09-09
Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Renal dosing, restrictions and evidence limits
Limits that apply to these rows
Renal impairment increases myopathy/rhabdomyolysis risk. Keep indexed units and the non-hemodialysis qualification. No HD dose is inferred.
Rosuvastatin - renal guidance
Indexed CLcr, mL/min/1.73 m2
Source-specific dose / instruction
<30, not receiving hemodialysis
Start 5 mg once daily; maximum 10 mg/day
Mild/moderate impairment
No specific renal adjustment in this source
Read the retained text before reformatting
For severe impairment with indexed CLcr <30 mL/min/1.73 m2 in a patient not receiving hemodialysis, start 5 mg once daily and do not exceed 10 mg/day. Mild/moderate impairment does not require a specific renal adjustment in this source. Renal impairment increases myopathy/rhabdomyolysis risk. Preserve the source's indexed creatinine-clearance units and nondialysis qualification rather than substituting an unindexed cutoff or extending this regimen to hemodialysis.
RDM52-rxlist-rosuvastatin-c2269d8a9f-C1 · Source locator: Dosage in severe renal impairment; renal population and myopathy risk.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.